Dartmouth Logo

Dartmouth Logo

Friday, September 6, 2013

Rare Diseases Clinical Research Consortia (RDCRC) for Rare Diseases Clinical Research Network (U54)

Funding Opportunity Announcement (FOA) Number
RFA-TR-13-002
Companion Funding Opportunity
Not Applicable
Number of Applications
Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.121, 93.847, 93.855, 93.856, 93.865, 93.837, 93.838, 93.839, 93.853, 93.846
Funding Opportunity Purpose
The purpose of this FOA is to facilitate clinical research in rare diseases through support for 1) collaborative clinical research in rare diseases, including longitudinal studies of individuals with rare diseases, clinical studies and/or clinical trials; 2) training of clinical investigators in rare diseases research; 3) pilot/demonstration (proof of concepts) clinical research projects; and 4) access to information related to rare diseases for basic and clinical researchers, academic and practicing physicians, patients, and the lay public. Items 1-4 must be addressed in the RDCRC application. Clinical data management for efficient data collection as well as data mining and data sharing across rare diseases will be addressed in the DMCC application. Another FOA will be published to address DMCC.

Key Dates

Posted Date
August 14, 2013
Letter of Intent Due Date(s)
October 7, 2013
Application Due Date(s)
November 7, 2013

1 comment:

  1. It is also a good practice for medical researchers about rare disease and I also want to know their possible outline about the study. I will looking forward for more about this. Thanks for the information.

    ReplyDelete